Since mutations in TP53 cause LFS and osteosarcoma is a defining tumor of the syndrome, SNPs in TP53 were evaluated as potential osteosarcoma risk factors in the Bone Disease and Injury Study of Osteosarcoma (BDISO), a hospital-based study of 104 cases and 74 controls [96]. Here, TP53 is linked to neoplasm.